![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SERPINA1 |
Gene summary for SERPINA1 |
![]() |
Gene information | Species | Human | Gene symbol | SERPINA1 | Gene ID | 5265 |
Gene name | serpin family A member 1 | |
Gene Alias | A1A | |
Cytomap | 14q32.13 | |
Gene Type | protein-coding | GO ID | GO:0002526 | UniProtAcc | E9KL23 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5265 | SERPINA1 | GSM4909286 | Human | Breast | IDC | 3.11e-02 | -1.91e-01 | 0.1081 |
5265 | SERPINA1 | GSM4909290 | Human | Breast | IDC | 8.79e-03 | -1.91e-01 | 0.2096 |
5265 | SERPINA1 | GSM4909301 | Human | Breast | IDC | 3.68e-04 | 2.40e-01 | 0.1577 |
5265 | SERPINA1 | GSM4909302 | Human | Breast | IDC | 6.44e-15 | 6.36e-01 | 0.1545 |
5265 | SERPINA1 | GSM4909304 | Human | Breast | IDC | 4.32e-16 | 2.50e-01 | 0.1636 |
5265 | SERPINA1 | GSM4909307 | Human | Breast | IDC | 4.05e-03 | 1.04e-01 | 0.1569 |
5265 | SERPINA1 | brca2 | Human | Breast | Precancer | 5.14e-12 | 4.66e-01 | -0.024 |
5265 | SERPINA1 | brca10 | Human | Breast | Precancer | 4.11e-19 | 8.21e-01 | -0.0029 |
5265 | SERPINA1 | NCCBC3 | Human | Breast | DCIS | 6.64e-04 | 2.31e-01 | 0.1198 |
5265 | SERPINA1 | P3 | Human | Breast | IDC | 1.52e-02 | 6.29e-01 | 0.1542 |
5265 | SERPINA1 | DCIS2 | Human | Breast | DCIS | 1.16e-03 | -8.83e-02 | 0.0085 |
5265 | SERPINA1 | CA_HPV_3 | Human | Cervix | CC | 2.80e-05 | -3.99e-01 | 0.0414 |
5265 | SERPINA1 | HSIL_HPV_2 | Human | Cervix | HSIL_HPV | 5.36e-03 | 2.94e-01 | 0.0208 |
5265 | SERPINA1 | CCI_1 | Human | Cervix | CC | 1.44e-06 | -5.63e-01 | 0.528 |
5265 | SERPINA1 | CCI_2 | Human | Cervix | CC | 9.89e-04 | -5.41e-01 | 0.5249 |
5265 | SERPINA1 | CCI_3 | Human | Cervix | CC | 3.97e-09 | -5.63e-01 | 0.516 |
5265 | SERPINA1 | CCII_1 | Human | Cervix | CC | 4.76e-13 | -5.63e-01 | 0.3249 |
5265 | SERPINA1 | Tumor | Human | Cervix | CC | 4.68e-22 | -5.61e-01 | 0.1241 |
5265 | SERPINA1 | sample1 | Human | Cervix | CC | 2.63e-07 | -5.37e-01 | 0.0959 |
5265 | SERPINA1 | sample3 | Human | Cervix | CC | 4.99e-20 | -5.56e-01 | 0.1387 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007596 | Stomach | CAG | blood coagulation | 16/552 | 217/18723 | 7.37e-04 | 1.13e-02 | 16 |
GO:0007599 | Stomach | CAG | hemostasis | 16/552 | 222/18723 | 9.40e-04 | 1.38e-02 | 16 |
GO:0050817 | Stomach | CAG | coagulation | 16/552 | 222/18723 | 9.40e-04 | 1.38e-02 | 16 |
GO:00525475 | Stomach | SIM | regulation of peptidase activity | 54/708 | 461/18723 | 1.46e-13 | 6.25e-11 | 54 |
GO:00525485 | Stomach | SIM | regulation of endopeptidase activity | 51/708 | 432/18723 | 5.26e-13 | 2.07e-10 | 51 |
GO:00513465 | Stomach | SIM | negative regulation of hydrolase activity | 42/708 | 379/18723 | 4.58e-10 | 8.00e-08 | 42 |
GO:00104665 | Stomach | SIM | negative regulation of peptidase activity | 33/708 | 262/18723 | 1.39e-09 | 2.26e-07 | 33 |
GO:00458615 | Stomach | SIM | negative regulation of proteolysis | 39/708 | 351/18723 | 1.80e-09 | 2.79e-07 | 39 |
GO:00109515 | Stomach | SIM | negative regulation of endopeptidase activity | 32/708 | 252/18723 | 2.01e-09 | 2.79e-07 | 32 |
GO:004206051 | Stomach | SIM | wound healing | 31/708 | 422/18723 | 3.48e-04 | 6.33e-03 | 31 |
GO:005087841 | Stomach | SIM | regulation of body fluid levels | 26/708 | 379/18723 | 2.64e-03 | 2.58e-02 | 26 |
GO:005254729 | Thyroid | HT | regulation of peptidase activity | 71/1272 | 461/18723 | 6.39e-11 | 9.11e-09 | 71 |
GO:005254829 | Thyroid | HT | regulation of endopeptidase activity | 64/1272 | 432/18723 | 2.80e-09 | 2.68e-07 | 64 |
GO:004586129 | Thyroid | HT | negative regulation of proteolysis | 54/1272 | 351/18723 | 1.31e-08 | 1.08e-06 | 54 |
GO:004206030 | Thyroid | HT | wound healing | 60/1272 | 422/18723 | 4.06e-08 | 2.69e-06 | 60 |
GO:005134628 | Thyroid | HT | negative regulation of hydrolase activity | 54/1272 | 379/18723 | 1.80e-07 | 9.53e-06 | 54 |
GO:001095126 | Thyroid | HT | negative regulation of endopeptidase activity | 40/1272 | 252/18723 | 4.32e-07 | 1.92e-05 | 40 |
GO:001046627 | Thyroid | HT | negative regulation of peptidase activity | 41/1272 | 262/18723 | 4.59e-07 | 2.02e-05 | 41 |
GO:000759617 | Thyroid | HT | blood coagulation | 28/1272 | 217/18723 | 8.06e-04 | 8.77e-03 | 28 |
GO:000759917 | Thyroid | HT | hemostasis | 28/1272 | 222/18723 | 1.15e-03 | 1.14e-02 | 28 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa046102 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa046103 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa046104 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
hsa046105 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SERPINA1 | SNV | Missense_Mutation | rs758293405 | c.134N>T | p.Pro45Leu | p.P45L | P01009 | protein_coding | tolerated(0.45) | benign(0) | TCGA-A8-A06U-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SERPINA1 | SNV | Missense_Mutation | c.4N>G | p.Pro2Ala | p.P2A | P01009 | protein_coding | tolerated(0.23) | benign(0.071) | TCGA-A8-A097-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD | |
SERPINA1 | SNV | Missense_Mutation | rs758293405 | c.134N>T | p.Pro45Leu | p.P45L | P01009 | protein_coding | tolerated(0.45) | benign(0) | TCGA-A8-A09G-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SERPINA1 | SNV | Missense_Mutation | rs139964603 | c.976N>A | p.Val326Ile | p.V326I | P01009 | protein_coding | tolerated(1) | benign(0.009) | TCGA-D8-A1JF-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SERPINA1 | SNV | Missense_Mutation | novel | c.331N>G | p.Ile111Val | p.I111V | P01009 | protein_coding | tolerated(0.71) | benign(0.012) | TCGA-E2-A572-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | doxorubicin | SD |
SERPINA1 | insertion | Frame_Shift_Ins | novel | c.488_489insTGTTCGCAGAAGGCTTGCGTTTCTCTGTCACTTTATCGGTG | p.Ser164ValfsTer60 | p.S164Vfs*60 | P01009 | protein_coding | TCGA-BH-A0AY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | SD | |||
SERPINA1 | SNV | Missense_Mutation | c.458A>C | p.Lys153Thr | p.K153T | P01009 | protein_coding | tolerated(0.07) | benign(0.175) | TCGA-A6-6653-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SERPINA1 | SNV | Missense_Mutation | rs11558261 | c.415N>A | p.Gly139Ser | p.G139S | P01009 | protein_coding | tolerated(0.1) | probably_damaging(0.964) | TCGA-CA-5254-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | oxaliplatin | CR |
SERPINA1 | SNV | Missense_Mutation | rs544632177 | c.740G>A | p.Arg247His | p.R247H | P01009 | protein_coding | tolerated(0.09) | benign(0.132) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SERPINA1 | SNV | Missense_Mutation | c.225N>A | p.Phe75Leu | p.F75L | P01009 | protein_coding | tolerated(0.33) | benign(0.248) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5265 | SERPINA1 | DRUGGABLE GENOME, PROTEASE INHIBITOR | Alpha1-proteinase inhibitor (human) modified process | |||
5265 | SERPINA1 | DRUGGABLE GENOME, PROTEASE INHIBITOR | Igmesine | IGMESINE | ||
5265 | SERPINA1 | DRUGGABLE GENOME, PROTEASE INHIBITOR | Glassia | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | ||
5265 | SERPINA1 | DRUGGABLE GENOME, PROTEASE INHIBITOR | AGTC-0106 |
Page: 1 |